ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,068.50
      0.03%
      US Tech 100
      21,138.80
      -0.15%
      Dow Jones
      44,593.65
      0.28%
      Brent Oil
      76.565
      -0.09%
      Bitcoin
      95,772.06
      0.02%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Barinthus Biotherapeutics PLC (BRNS) Quote

      Barinthus Biotherapeutics PLC

      Barinthus Biotherapeutics PLC (BRNS)

      NASDAQ
      1.08
      0.07
      (6.93%)
      Closed February 12 4:00PM
      Delayed by 15 minutes
      1.08
      0.00
      (0.00%)
      After Hours: 6:56PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.08
      Bid
      1.02
      Ask
      1.08
      Volume
      17,024
      1.00 Day's Range 1.09
      0.00 52 Week Range 0.00
      Market Cap
      43.447M
      Previous Close
      1.01
      Open
      1.00
      Last Trade
      11
      @
      1.08
      Last Trade Time
      Financial Volume
      $ 17,967
      VWAP
      1.0554
      Average Volume (3m)
      -
      Shares Outstanding
      40,228,456
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      1.88M
      Net Profit
      -73.35M

      About Barinthus Biotherapeutics PLC

      Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current proph... Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current prophylactic programs include VTP-400. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca. Show more

      Sector
      Offices-holdng Companies,nec
      Industry
      Offices-holdng Companies,nec
      Website
      www.barinthusbio.com/
      Headquarters
      Oxfordshire, Gbr
      Founded
      -
      Barinthus Biotherapeutics PLC is listed in the Offices-holdng Companies sector of the NASDAQ with ticker BRNS. The last closing price for Barinthus Biotherapeutics was $1.01. Over the last year, Barinthus Biotherapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

      Barinthus Biotherapeutics currently has 40,228,456 shares outstanding. The market capitalization of Barinthus Biotherapeutics is $40.63 million.

      Ask ADVFN Intelligence (AI)

      BRNS Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 05 2025
      BRNS (6.93%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 05 2025
      BRNS (6.93%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 05 2025
      BRNS (6.93%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 10 2025
      BRNS (6.93%)

      Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
      Edgar (US Regulatory)
      December 31 2024
      BRNS (6.93%)

      Form 3 - Initial statement of beneficial ownership of securities
      Edgar (US Regulatory)
      December 20 2024
      BRNS (6.93%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 25 2024
      BRNS (6.93%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 15 2024
      BRNS (6.93%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      BRNS - Frequently Asked Questions (FAQ)

      What is the current Barinthus Biotherapeutics share price?
      The current share price of Barinthus Biotherapeutics is $ 1.08
      How many Barinthus Biotherapeutics shares are in issue?
      Barinthus Biotherapeutics has 40,228,456 shares in issue
      What is the market cap of Barinthus Biotherapeutics?
      The market capitalisation of Barinthus Biotherapeutics is USD 40.63M
      What is the 1 year trading range for Barinthus Biotherapeutics share price?
      Barinthus Biotherapeutics has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the reporting currency for Barinthus Biotherapeutics?
      Barinthus Biotherapeutics reports financial results in USD
      What is the latest annual turnover for Barinthus Biotherapeutics?
      The latest annual turnover of Barinthus Biotherapeutics is USD 1.88M
      What is the latest annual profit for Barinthus Biotherapeutics?
      The latest annual profit of Barinthus Biotherapeutics is USD -73.35M
      What is the registered address of Barinthus Biotherapeutics?
      The registered address for Barinthus Biotherapeutics is UNIT 6-10, ZEUS BUILDING, RUTHERFORD AVENUE, HARWELL, OXFORDSHIRE, OX11 0DF
      What is the Barinthus Biotherapeutics website address?
      The website address for Barinthus Biotherapeutics is www.barinthusbio.com/
      Which industry sector does Barinthus Biotherapeutics operate in?
      Barinthus Biotherapeutics operates in the OFFICES-HOLDNG COMPANIES,NEC sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AIFFFirefly Neuroscience Inc
      $ 8.34
      (169.03%)
      		195.41M
      SOPASociety Pass Inc
      $ 5.70
      (119.23%)
      		52.99M
      OMGAOmega Therapeutics Inc
      $ 0.1916
      (77.41%)
      		319.92M
      LTRYLottery com Inc
      $ 2.19
      (76.61%)
      		56.53M
      SHOTWSafety Shot Inc
      $ 0.1866
      (58.81%)
      		2.82k
      FTELFitell Corporation
      $ 1.00
      (-53.49%)
      		7.43M
      FLNCFluence Energy Inc
      $ 6.995
      (-46.48%)
      		53.39M
      BLACBellevue Life Sciences Acquisition Corporation
      $ 6.31
      (-42.32%)
      		57.15k
      BLACUBellevue Life Sciences Acquisition Corporation
      $ 6.57
      (-41.86%)
      		40.26k
      CMCOColumbus McKinnon Corporation
      $ 20.885
      (-41.14%)
      		4.57M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.090449
      (31.09%)
      		1.12B
      CYNCYNGN Inc
      $ 0.1605
      (-13.10%)
      		922.9M
      OCEAOcean Biomedical Inc
      $ 0.1999
      (35.07%)
      		562.11M
      OMGAOmega Therapeutics Inc
      $ 0.1916
      (77.41%)
      		319.92M
      INABIN8bio Inc
      $ 0.2951
      (9.26%)
      		226.83M

      BRNS Discussion

      View Posts
      db7 db7 3 months ago
      2 days to AASLD...
      👍️0
      db7 db7 4 months ago
      .. and here is that block buyer from the 7th: https://investors.barinthusbio.com/node/8831/html
      👍️0
      db7 db7 4 months ago
      abnormal volume today, vol over 200k with large blocks traded 1.27-1.275
      👍️0
      db7 db7 5 months ago
      $1.33 today
      👍️0
      db7 db7 5 months ago
      https://www.marketbeat.com/instant-alerts/nasdaq-brns-sec-filing-2024-09-03/
      👍️0
      Monksdream Monksdream 7 months ago
      BRNS under $2
      👍️0
      db7 db7 10 months ago
      https://www.labiotech.eu/in-depth/hepatitis-b-cure/
      👍️0

      Your Recent History

      NASDAQ
      BRNS
      Barinthus Biotherapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads